Pharmaceutical Industry

143 - 1984 pharmaceuticals in developing
Publication

Pharmaceuticals in Developing Countries 1981-82

1 July 1984

Two years ago, the Office of Health Economics published a research paper describing some of the activities of eighteen European pharmaceutical companies in the Developing Countries…

The future for pharmaceuticals cover page
Publication

Future for Pharmaceuticals: the Potential; the Pattern and the Problems

1 June 1983

Britain has very little to be proud of on the industrial front in the 1980s. Many of its traditional industries — the so-called ‘smokestack industries’ —…

129 - 1982 the costs and benefits of regulating
Publication

Costs and Benefits of Regulating New Product Development in the UK Pharmaceutical Industry

3 January 1982

This is the second in an occasional series of Pharmaceutical Industry Papers to be published by OHE. The first concerned prices; this second paper is concerned,…

The pharma society cover page
Publication

Pharmaceutical Industry and Society: a Study of the Changing Environment and Economics of the International Industry

1 July 1972

This paper is based on a symposium held at the Imperial College of Science and Technology by the Office of Health Economics in 1972. Our ancestors…

142 - 1984 pharmaceuticals among the sunrise
Publication

Pharmaceuticals Among the Sunrise Industries

1 February 1984

The performance of the United Kingdom economy has been the subject of much critical comment in recent years. Of course, economic achievement can be viewed from…

Economics and innovation in the pharma industry cover page
Publication

Economics and Innovation the Pharmaceutical Industry

1 July 1969

This book contains the third series of Winter Lectures organised by the Office of Health Economics, and the first to be given after the publication of…

Medicines in the 1990s cover page
Publication

Medicines in the 1990s: a Technological Forecast

1 July 1969

By 1990, the total cost of the National Health Service will probably have reached about £10,000 million of which about £1,300 million will be for medicines…